ПБиМ 2023 №3,1 (145)
Subject of the article
ANALYSIS OF INTERNAL GLAND LESIONS IN PATIENTS WITH COVID-19 (255-257)
Authors
Orzikulov Azam Orzikulovich, Nurimov Pahlavon Bakhtioyrovich
Institution
Samarkand State Medical University, Republic of Uzbekistan, Samarkand
Abstract
COVID-19 claimed the lives of millions of people during the pandemic. The disease is more severe in people with diabetes, and these patients attracted the attention of endocrinologists during the pandemic, the true endocrine manifestations of COVID-19 have not yet been studied in detail. Data on the defeat of the pituitary gland, hypothalamus, thyroid gland and adrenal glands by coronavirus, their structural and functional disorders in COVID-19 disease are scarce due to the lack of reliable results of clinical studies before and after the disease. Studies have shown that disor-ders of the immune response play an important role in the development of diseases of the endocrine system (diabetes mellitus, thyroid diseases, autoimmune syndromes, adrenal insufficiency, etc.). Endocrine pathologies are among the most severe chronic diseases. There is a risk of provocative effects of COVID-19 on the development and progression of endocrinopathies. The study of the mechanisms of action of COVID-19 on the endocrine system is currently being initiated by researchers.
Key words
hormones, COVID-19, endocrine glands.
Literature
1. Kaiser UB, Mirmira RG, Stewart PM. Our re-sponse to COVID-19 as endocrinologists and dia-betologists. J Clin Endocr Metab. 2020;105(5):dgaa148. 2. Boelaert K, Visser WE, Taylor PN, et al. Endocrinology in the time of COVID-19: management of hyper- and hypo- thyroidism. Eur J Endocrinol. 2020;183(1):G33-G39. 3. Мокрышева Н.Г., Галстян Г.Р., Киржаков М.А., и др. Пандемия COVID-19 и эндокринопатии // Проблемы эндокринологии. - 2020. - Т.66. - №1. [Mokrysheva NG, Galstyan GR, Kirzhakov MA, et al. Pandemiya COVID-19 i endokrinopatii. Problemy endokrinologii. 2020;66(1). (In Russ).] 4. Vrachimis A, Iacovou I, Giannoula E, Giovanella L. Endocrinology in the time of COVID-19: management of thyroid nodules and cancer. Eur J Endocrinol. 2020;183(1):G41-G48. 5. Pal R, Banerjee M. COVID 19 and the endocrine system: exploring the unexplored. J Endocrinol Invest. 2020;43(7):1027-1031. 6. Nurimov P.B., Bobokandova M.F. “Ўсмир ёшдаги ўғил болаларда гипофиз ва буйрак усти безининг соматотропик функцияси ривожланиш хусусиятлари». Тиббиётда янги кун. Илмий рефератив, маънавий маърифий журнал. 2 (40) 2022 йй. РР: 625-628. 9. Karabayev A. G., Nurimov P. B. “Reactivity of the supraoptic, arcuate nucleus of the hypothalamus and the B- and D-basophilic cells of the adenohypophysis in the early postreanimation period”. European Journal of Molecular & Clinical Medicine. Volume 08, Issue 03, 2021. РР: 954-957. 10. Нуримов П.Б., Анваров Ж.А. «Анализ функциональных изменений гипофиза и надпочечников при Covid-19» Оңтүстік қазақстан медицина академиясы, хабаршы №2(96), 2022 (of the south-kazakhstan medicina academy republican scientific journal). С.112-115.